Cibus Toxsorb Oral Powder

Indications

• Infections (topical treatment)
• Wound care (as an antiseptic)
• Ear infections (as an ear drop solution)
• Acid-base balance in metabolic acidosis

Dosage

Children: Refer to established guidelines as dosage may vary based on the formulation and indication.

Adults: Refer to established guidelines as dosage may vary based on the formulation and indication.

Mechanism of action

Acetic acid exerts its effects primarily through its ability to lower pH levels, creating an acidic environment which is inhospitable to many pathogens. It can disrupt the integrity of microbial cell membranes, leading to cell lysis and death. Additionally, acetic acid can promote the healing of wounds and enhance the absorption of certain medications when used as a solvent.

Pharmacodynamics

The pharmacodynamics of acetic acid involve its interaction with biological systems, leading to changes in cellular functions. Its acidic nature helps in the denaturation of proteins and disruption of microbial metabolism. This contributes to its antibacterial and antifungal activities, making it effective against a range of pathogens.

Pharmacokinetics

Acetic acid is rapidly absorbed in the gastrointestinal tract when ingested. It is metabolized primarily in the liver, converting to acetyl CoA and subsequently entering various metabolic pathways including the citric acid cycle. The elimination half-life varies but is generally short, with excretion occurring mainly via urine. When applied topically, absorption is minimal, and local effects are predominant.

Pregnancy

The safety of acetic acid during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

There is no specific information available regarding the use of acetic acid during breastfeeding. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed in a well-ventilated area.

Indications

• Acute poisoning
• Drug overdose
• Gastrointestinal decontamination

Dosage

Children: Refer to specific pediatric dosing recommendations based on the child's weight and the clinical situation.

Adults: Refer to specific guidelines depending on the type of poisoning and the clinical scenario.

Mechanism of action

Activated charcoal works through a process called adsorption, where toxins and drugs adhere to the surface of the charcoal particles due to electrostatic attractions and Van der Waals forces. This prevents the absorption of these substances in the gastrointestinal tract, allowing them to be excreted from the body.

Pharmacodynamics

The pharmacodynamic effects of activated charcoal are related to its ability to bind a wide range of substances. The efficacy of activated charcoal varies depending on the type and amount of the toxin or drug ingested, as well as the time elapsed since ingestion. Generally, activated charcoal is most effective when administered within one hour of ingestion of a toxic substance.

Pharmacokinetics

Activated charcoal is not absorbed by the gastrointestinal tract; instead, it remains in the gut, where it binds to ingested substances and promotes their elimination via feces. Its effects are dose-dependent, and it is typically administered as a single dose, although multiple doses may be considered in certain cases of severe poisoning.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Aspiration pneumonia (if inhaled)
• Electrolyte imbalances

Precautions

• Use with caution in patients with gastrointestinal obstruction
• Monitor for potential aspiration in patients with reduced consciousness
• Consider electrolyte levels in patients with significant diarrhea or vomiting

Pregnancy

Activated charcoal is generally considered safe for use in pregnancy, but consult a healthcare professional before use.

Breast-feeding

Activated charcoal is excreted in breast milk, use with caution and consult a healthcare professional.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Activated charcoal powder
• Activated charcoal capsules
• Activated charcoal tablets

Indications

• Gastrointestinal disturbances
• Toxin adsorption in cases of poisoning
• Diarrhea
• Gastroenteritis

Dosage

Children: Refer to the specific product guidelines or consult clinical resources for dosing recommendations.

Adults: Refer to the specific product guidelines or consult clinical resources for dosing recommendations.

Mechanism of action

Bentonite works by adsorbing toxins and pathogens in the gastrointestinal tract. The high surface area and negative charge of bentonite particles attract positively charged ions, allowing it to bind to various substances, including bacteria and toxins, thereby facilitating their removal from the body.

Pharmacodynamics

Bentonite's pharmacodynamic properties are largely attributed to its adsorptive capacity. It can effectively bind to various drugs and toxins, reducing their bioavailability. This property makes it useful in treating cases of poisoning or overdose, as it can prevent the absorption of harmful substances in the intestines.

Pharmacokinetics

Bentonite is not absorbed systemically. After oral administration, it remains in the gastrointestinal tract where it exerts its effects. The clay is eventually excreted in the feces. The onset of action can vary depending on the formulation and the presence of other substances in the gastrointestinal tract.

Adverse effects

• Constipation
• Abdominal discomfort
• Nausea

Interactions

• May reduce the absorption of other medications when taken concurrently

Precautions

• Use with caution in patients with gastrointestinal obstructions
• Ensure adequate hydration to prevent constipation

Pregnancy

Bentonite is generally considered safe during pregnancy; however, clinical data is limited.

Breast-feeding

Bentonite is likely safe during breastfeeding, but consult a healthcare professional for personalized advice.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powder
• Capsules
• Suspension

Indications

• Topical treatment of fungal infections
• Preservative in food and pharmaceutical products
• Treatment of hyperammonemia (as part of a combination therapy)

Dosage

Children: Refer to specific product guidelines and clinical protocols for pediatric dosing information.

Adults: Refer to specific product guidelines and clinical protocols for dosing information.

Mechanism of action

Benzoic acid exerts its antimicrobial effects primarily by disrupting the integrity of microbial cell membranes, leading to cell lysis. It can also inhibit certain metabolic pathways in bacteria, such as the conversion of pyruvate to acetyl-CoA, thereby limiting energy production in these organisms.

Pharmacodynamics

Benzoic acid demonstrates a concentration-dependent antibacterial and antifungal activity. The efficacy of benzoic acid is influenced by the pH of the environment; it is more effective in acidic conditions. The compound acts on a broad spectrum of microorganisms, including some bacteria and fungi, making it a useful preservative and therapeutic agent.

Pharmacokinetics

Benzoic acid is absorbed through the gastrointestinal tract when ingested and can be metabolized in the liver. It is primarily excreted in the urine as hippuric acid after conjugation with glycine. The half-life of benzoic acid varies but is generally around 1 to 2 hours. Its distribution in the body is rapid, with a volume of distribution that suggests extensive tissue binding.

Adverse effects

• Allergic reactions
• Skin irritation
• Nausea
• Vomiting
• Headache

Precautions

• Use with caution in individuals with known hypersensitivity to benzoates
• Monitor for signs of hypersensitivity reactions

Pregnancy

The safety of benzoic acid during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Benzoic acid is excreted in breast milk. Caution is advised when administered to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Formulations

• Topical creams
• Ointments
• Solutions

Indications

• Acute poisoning
• Drug overdose
• Gastrointestinal decontamination
• Treatment of certain types of toxin ingestion

Dosage

Children: For children over 1 year of age, the recommended dosage of activated charcoal is 1 gram per kilogram of body weight, up to a maximum of 50 grams. For children under 1 year, consult the BNF for Children for specific dosing guidance.

Adults: The usual adult dosage for activated charcoal in the treatment of poisoning is 50 to 100 grams, administered orally or via a nasogastric tube. Repeat doses may be given in certain cases, depending on the toxin involved.

Mechanism of action

Activated charcoal works primarily by adsorbing toxins and drugs in the gastrointestinal tract, reducing their systemic absorption. The extensive surface area and porous structure of activated charcoal allow it to bind various substances through van der Waals forces and hydrogen bonding. This binding action helps to prevent the absorption of harmful substances into the bloodstream, facilitating their elimination from the body.

Pharmacodynamics

The efficacy of activated charcoal is related to its ability to adsorb a wide range of substances, including many pharmaceuticals and poisons. The effectiveness can vary depending on the specific substance, the timing of administration, and the dose of activated charcoal. It is generally most effective when administered soon after ingestion of the toxin.

Pharmacokinetics

Activated charcoal is not absorbed systemically; it acts locally within the gastrointestinal tract. After administration, it passes through the gastrointestinal system and is eventually excreted in the feces. The adsorption capacity of activated charcoal is influenced by factors such as the surface area, particle size, and the nature of the toxin to which it is exposed.

Contra-indications

• Intestinal obstruction
• Gastrointestinal perforation
• Severe constipation

Adverse effects

• Gastrointestinal disturbances such as nausea and vomiting
• Constipation
• Black stools
• Aspiration pneumonia if inhaled

Interactions

• May reduce the absorption of certain medications, including anticoagulants, anticonvulsants, and others
• Should not be given simultaneously with other oral medications

Precautions

• Use with caution in patients with a history of gastrointestinal disorders
• Ensure airway protection in unconscious or compromised patients to prevent aspiration
• Monitor for potential electrolyte imbalances

Pregnancy

Charcoal is generally considered safe during pregnancy, but should only be used when necessary and under medical supervision.

Breast-feeding

Charcoal is unlikely to adversely affect a nursing infant, but should be used with caution.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Activated charcoal tablets
• Activated charcoal powder
• Activated charcoal suspension

Indications

• Acidulant in food and beverages
• Preservative in pharmaceutical formulations
• pH adjuster in various chemical preparations

Dosage

Children: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Adults: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Mechanism of action

Citric acid acts by chelating metal ions, which can enhance the solubility of certain compounds and improve their bioavailability. It also contributes to the acidity of the environment, which can influence enzymatic activity and metabolic pathways, particularly in the degradation of citronellol.

Pharmacodynamics

Citric acid exhibits mild pharmacological effects primarily attributed to its role in metabolic processes. It aids in the regulation of pH levels, which can impact enzymatic reactions and biochemical pathways. The acid's chelating properties may help to reduce the toxicity of certain metal ions in biological systems.

Pharmacokinetics

Citric acid is rapidly absorbed after oral administration and is metabolized in the liver. It undergoes conversion to various metabolites in the citric acid cycle, contributing to energy production. The elimination primarily occurs through urine, with minimal accumulation in the body.

Pregnancy

Citric acid is generally regarded as safe during pregnancy when used in food amounts. However, consult a healthcare provider for advice on medicinal use.

Breast-feeding

Citric acid is considered safe during breastfeeding when consumed in food amounts. For medicinal use, consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Mechanism of action

Ethylenediamine acts as a gamma-aminobutyric acid (GABA) agonist by enhancing the binding of labeled diazepam to rat forebrain membrane preparations in a bicuculline-sensitive manner. Although it has significantly lower potency compared to GABA, it serves as an inhibitor of beta-alanine uptake in the cerebral cortex. Additionally, ethylenediamine facilitates the release of labeled GABA from glial cells in the retina, indicating its involvement in neurotransmitter modulation.

Pharmacodynamics

Ethylenediamine exhibits weak GABAergic activity, being 700-800 times less potent than GABA itself in enhancing diazepam binding. Its primary action is as an inhibitor of beta-alanine uptake, which may have implications for neurotransmitter balance in the central nervous system. The compound's effects on GABA release suggest a role in the modulation of inhibitory neurotransmission, although further studies are necessary to fully elucidate its pharmacodynamic profile.

Pharmacokinetics

The pharmacokinetics of ethylenediamine are not extensively documented in the literature. However, as a small organic molecule, it is likely to be absorbed readily upon administration. The distribution, metabolism, and excretion pathways are not well characterized, warranting further investigation to elucidate its pharmacokinetic properties.

Pregnancy

There are no well-controlled studies in pregnant women. Ethylenediamine should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether ethylenediamine is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep container tightly closed.

Indications

• Lead poisoning
• Mercury poisoning
• Arsenic poisoning
• Hypercalcemia
• Calcinosis

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations tailored to the paediatric population.

Adults: Refer to established clinical guidelines for specific dosing based on the condition being treated, as dosages can vary widely.

Mechanism of action

Tetraacetic acid functions by forming stable, water-soluble complexes with divalent and trivalent metal ions. This chelation reduces the concentration of free metal ions in the bloodstream, facilitating their excretion through the kidneys. The binding of metal ions prevents their reactivity and toxicity, thus mitigating the harmful effects associated with heavy metal exposure.

Pharmacodynamics

The pharmacodynamic effects of tetraacetic acid primarily involve the reduction of metal ion toxicity. By chelating metals such as lead, mercury, and arsenic, EDTA decreases their bioavailability and promotes their elimination from the body. This action can lead to improvements in clinical symptoms associated with heavy metal poisoning, including neurological, gastrointestinal, and renal effects.

Pharmacokinetics

Tetraacetic acid is administered intravenously or intramuscularly, with rapid distribution in the body. It has a low oral bioavailability and is primarily eliminated via the kidneys through glomerular filtration. The half-life of EDTA is approximately 1 to 2 hours, but the complexed metal ions may have a longer duration of action due to their slower elimination.

Pregnancy

Safety during pregnancy has not been established. Caution is advised.

Breast-feeding

It is not known if tetraacetic is excreted in breast milk. Caution should be exercised.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Gastrointestinal disturbances
• Diarrhea associated with antibiotic use
• Irritable bowel syndrome (IBS)
• Support for digestive health
• Enhancement of nutrient absorption

Dosage

Children: Refer to specific product guidelines for appropriate dosing, as doses may vary by formulation.

Adults: Refer to specific product guidelines for appropriate dosing, as doses may vary by formulation.

Mechanism of action

Yeasacc functions by restoring the balance of gut flora through the introduction of beneficial yeast. It competes with pathogenic microorganisms for resources, thereby inhibiting their growth. This competitive exclusion helps to maintain a healthy gut environment. Additionally, it may enhance the immune response by stimulating mucosal immune functions and producing metabolites that are beneficial for gut health.

Pharmacodynamics

The pharmacodynamics of Yeasacc involve its role in modulating the gut microbiome composition, which can lead to improvements in digestive health. The live yeast cells can produce enzymes that aid in the breakdown of dietary fibers and other complex carbohydrates, facilitating better nutrient absorption. The overall effect of Yeasacc is an enhancement of intestinal barrier function and a reduction in gastrointestinal disturbances such as diarrhea.

Pharmacokinetics

The pharmacokinetics of Yeasacc are not extensively documented, as it primarily acts locally within the gastrointestinal tract. The live yeast cells survive the acidic environment of the stomach and reach the intestines, where they exert their effects. The duration of action is typically related to the survival of these live organisms, and regular intake may be necessary to maintain its benefits.

Pregnancy

Yeasacc is generally considered safe during pregnancy, however, it is always recommended to consult a healthcare professional before use.

Breast-feeding

Yeasacc is usually deemed safe during breastfeeding, but it is advisable to seek medical advice prior to use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Mechanism of action

Ethylenediamine (EDA) acted as a gamma-aminobutyric acid (GABA) agonist by enhancing (3)H-labeled diazepam binding to well-washed rat forebrain membrane prepn in a bicuculline-sensitive manner, although its potency was 700-800 fold less than that of gamma-aminobutyric acid. Ethylenediamine was more than 3750-fold weaker than gamma-aminobutyric acid as a displacer of (3)H-gamma-aminobutyric acid bound to membrane receptors & was more than 40-fold weaker than gamma-aminobutyric acid at (3)H-gamma-aminobutyric acid uptake sites. Its most potent action was as an inhibitor of beta-alanine uptake into rat cerebral cortex slices. The release of (3)H gamma-aminobutyric acid (GABA) from Mueller (glial) cells was studied in the rat retina by a double isotope-labeling technique in which Mueller cells are preloaded with (3)H-gamma-aminobutyric acid while a population of neurons is prelabeled with (14)C-labeled glycine. The effects of 2 depolarizing agents, high K+ and veratridine, and the gamma-aminobutyric acid mimetic, ethylenediamine (EDA), on transmitter release from glial cells and neurons were simultaneously determined. Ethylenediamine released (3)H-gamma-aminobutyric acid readily, whereas little (14)C-glycine release was observed.